{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "MIND MEDICINE (MINDMED)", "longName": "Mind Medicine (MindMed) Inc.", "messageBoardId": "finmb_631045282", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": -2.6592014, "regularMarketPrice": 2.782, "marketState": "REGULAR", "firstTradeDateMilliseconds": 1583305200000, "priceHint": 4, "epsTrailingTwelveMonths": -1.56, "sharesOutstanding": 38595300, "bookValue": 3.404, "fiftyDayAverage": 2.9992, "fiftyDayAverageChange": -0.21720004, "fiftyDayAverageChangePercent": -0.07241932, "twoHundredDayAverage": 4.3990374, "twoHundredDayAverageChange": -1.6170373, "twoHundredDayAverageChangePercent": -0.3675889, "marketCap": 110318544, "priceToBook": 0.8172738, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "regularMarketChange": -0.075999975, "regularMarketTime": 1683892036, "regularMarketDayHigh": 2.782, "regularMarketDayRange": "2.756 - 2.782", "regularMarketDayLow": 2.756, "regularMarketVolume": 146, "regularMarketPreviousClose": 2.858, "bid": 2.792, "ask": 2.938, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 2.758, "averageDailyVolume3Month": 169, "averageDailyVolume10Day": 61, "fiftyTwoWeekLowChange": 0.822, "fiftyTwoWeekLowChangePercent": 0.41938776, "fiftyTwoWeekRange": "1.96 - 19.8", "fiftyTwoWeekHighChange": -17.018, "fiftyTwoWeekHighChangePercent": -0.859495, "fiftyTwoWeekLow": 1.96, "fiftyTwoWeekHigh": 19.8, "earningsTimestamp": 1683232200, "earningsTimestampStart": 1691578740, "earningsTimestampEnd": 1692014400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "MMQ.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "One World Trade Center", "address2": "Suite 8500", "city": "New York", "state": "NY", "zip": "10007", "country": "United States", "phone": "650 208 2454", "website": "https://www.mindmed.co", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company also develops MM-110, an a3\u00df4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. The company is headquartered in New York, New York.", "fullTimeEmployees": 48, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert  Barrow", "age": 33, "title": "CEO & Director", "yearBorn": 1989, "fiscalYear": 2022, "totalPay": {"raw": 956101, "fmt": "956.1k", "longFmt": "956,101"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Schond L. Greenway", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 343283, "fmt": "343.28k", "longFmt": "343,283"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Daniel Rollings Karlin M.A., M.D.", "age": 41, "title": "Chief Medical Officer", "yearBorn": 1981, "fiscalYear": 2022, "totalPay": {"raw": 663630, "fmt": "663.63k", "longFmt": "663,630"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Miriam Halperin Wernli Ph.D.", "age": 69, "title": "Exec. Pres", "yearBorn": 1953, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Scott M. Freeman M.D.", "age": 65, "title": "Co-Founder & Clinical Advisor", "yearBorn": 1957, "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Leonard  Latchman", "title": "Co-founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Carrie F. Liao CPA, CGMA", "title": "VP & Chief Accounting Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Maxim  Jacobs C.F.A.", "title": "VP of Investor Relations & Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mark R. Sullivan J.D.", "age": 51, "title": "Chief Legal Officer & Corp. Sec.", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Francois P. Lilienthal M.B.A., M.D.", "title": "Chief Commercial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 9, "boardRisk": 4, "compensationRisk": 9, "shareHolderRightsRisk": 4, "overallRisk": 6, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}